Safety, Tolerability and Efficacy of Immunomodulation With AT-1501 in Islet Cell Transplantation
Clinical trial NCT04711226 · WITHDRAWN
Trial details
- NCT number
- NCT04711226
- Sponsor
- Anelixis Therapeutics, LLC
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-19
- Primary completion
- 2024-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.